6681.HK

BrainAurora Medical Technology Ltd. (6681.HK) shares opened unchanged in their Hong Kong trading debut on Wednesday, after the company priced the shares at HK$3.22 apiece. The shares continued to trade in a narrow range after that.

The company said it sold approximately 181 million shares in the offering. The Hong Kong portion was oversubscribed by 10.4 times, while the international placement was only fully subscribed.

The company mainly provides cognitive impairment DTx products for hospitals and recorded combined losses of 1.67 billion yuan ($228 million) in the three and a half years from 2021 through the first half of last year. The listing raised net proceeds of about HK$500 million ($64 million), of which approximately 40% will be used for conducting further R&D, and 40% will go to assisting hospitals in establishing new cognitive centers.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Noah does wealth management

Noah finds second life in overseas voyage

The wealth manager’s international businesses drove it back to revenue growth in the second quarter as challenges continued to linger at home Key Takeaways: Noah Holdings’ overseas revenue increased about…
Illustration of China solar industry

China moves to end solar bloodbath, as East Buy chases warehouse club crown

China is floating yet another plan to rescue its oversupplied solar sector, including a mass shuttering of excess capacity. Will the government-led effort work this time? And a former online educator says it wants to become the new online Sam's Club of China. Does East Buy have what it takes to succeed?